Jacobson Weighs Consumer Health IPO
Executive Summary
Hong Kong's Jacobson Pharma is preparing to spin off its health and wellness portfolio from its dominant generic drug operation to enhance the growth prospects of both businesses.
You may also be interested in...
Sweden Seeks To Tackle Opioid Overdose Deaths With Naloxone Rx-To-OTC Switch
Opioid antagonist naloxone will soon be available without prescription in Sweden following a successful Rx-to-OTC application from Norway's DNE Pharma.
Norway's Orkla Prioritizes Seeing Off Private-Label Consumer Health Challenge
Alongside addressing the threat posed by private-label, Orkla Health CEO Isabelle Ducellier will over the coming three years focus on building global brands and simplifying the value chain to improve efficiency and extract synergies.
Poland's Government Pushing To Restore OTC Access To Morning After Pill
As Poland is ranked the worst country in Europe for contraception access by a group of EU parliamentarians, the country's government has voted through a bill which would make the morning after pill available without a prescription for the first time in more than six years.